Carcinogenesis, Vol. 23, No. 11, 1885-1895,
November 2002
© 2002 Oxford University Press
CARCINOGENESIS |
Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells
1 Laboratoire de Biologie du Développement, UPRES-EA 1033, SN3, USTL, 59655 Villeneuve d’Ascq Cedex,
2 Laboratoire de Pathologie Comparée, UMR8507, INRA/CNRS/UMII, cc101, 34095 Montpellier Cedex 5,
3 Laboratoire Assemblage et Réplication du Virus de l’Hépatite C, FRE CNRS 2369, IBL, BP 447, 59021 Lille Cedex and
4 Laboratoire d’Immunopathologie Cellulaire des Maladies Infectieuses, UMR 8527, IBL, BP 447, 59021 Lille Cedex, France
The maternally expressed H19 gene is transcribed as an untranslated RNA that serves as a riboregulator. We have previously reported that this transcript accumulates in epithelial cells in ~10% of breast cancers. To gain further insight on how the overexpression of the H19 gene affects the phenotype of human breast epithelial cells, we investigated the oncogenic potential of RNA that was abundantly expressed from MDA-MB-231 breast cancer cells stably transfected with the genomic sequence of the human H19 gene. The amount of H19 RNA did not affect cell proliferation capacity, timing of cell cycle phases or anchorage-dependent ability of H19-transfected clones in vitro. But in anchorage-independent growth assays the H19-recombined cells formed more and larger colonies in soft-agar versus control cells. To explore this phenotypic change, we analysed tumour development after subcutaneous injection of H19-recombined cells into scid mice. Results showed that H19 overexpression promotes tumour progression. These data support the hypothesis that an overload of H19 transcript is associated with cells exhibiting higher tumorigenic phenotypes and therefore we conclude that the H19 gene has oncogenic properties in breast epithelial cells.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. R. R. Forrest, R. F. Abdelhamid, and P. Carninci Annotating non-coding transcription using functional genomics strategies Brief Funct Genomic Proteomic, November 1, 2009; 8(6): 437 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. K. Mimouni, R. B. Lyngso, S. Griffiths-Jones, and J. Hein An Analysis of Structural Influences on Selection in RNA Genes Mol. Biol. Evol., January 1, 2009; 26(1): 209 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Berteaux, N. Aptel, G. Cathala, C. Genton, J. Coll, A. Daccache, N. Spruyt, H. Hondermarck, T. Dugimont, J.-J. Curgy, et al. A Novel H19 Antisense RNA Overexpressed in Breast Cancer Contributes to Paternal IGF2 Expression Mol. Cell. Biol., November 15, 2008; 28(22): 6731 - 6745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. V. Prasanth and D. L. Spector Eukaryotic regulatory RNAs: an answer to the 'genome complexity' conundrum Genes & Dev., January 1, 2007; 21(1): 11 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Barsyte-Lovejoy, S. K. Lau, P. C. Boutros, F. Khosravi, I. Jurisica, I. L. Andrulis, M. S. Tsao, and L. Z. Penn The c-Myc Oncogene Directly Induces the H19 Noncoding RNA by Allele-Specific Binding to Potentiate Tumorigenesis. Cancer Res., May 15, 2006; 66(10): 5330 - 5337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Fellig, I Ariel, P Ohana, P Schachter, I Sinelnikov, T Birman, S Ayesh, T Schneider, N de Groot, A Czerniak, et al. H19 expression in hepatic metastases from a range of human carcinomas J. Clin. Pathol., October 1, 2005; 58(10): 1064 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Berteaux, S. Lottin, D. Monte, S. Pinte, B. Quatannens, J. Coll, H. Hondermarck, J.-J. Curgy, T. Dugimont, and E. Adriaenssens H19 mRNA-like Noncoding RNA Promotes Breast Cancer Cell Proliferation through Positive Control by E2F1 J. Biol. Chem., August 19, 2005; 280(33): 29625 - 29636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Liao, M. Patel, Y. Hu, S. Charles, D. J. Herrick, and G. Brewer Targeted Knockdown of the RNA-binding Protein CRD-BP Promotes Cell Proliferation via an Insulin-like Growth Factor II-dependent Pathway in Human K562 Leukemia Cells J. Biol. Chem., November 19, 2004; 279(47): 48716 - 48724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Berteaux, S Lottin, E Adriaenssens, F Van Coppenolle, X Leroy, J Coll, T Dugimont, and J-J Curgy Hormonal regulation of H19 gene expression in prostate epithelial cells J. Endocrinol., October 1, 2004; 183(1): 69 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Tessier, G. A. Doyle, B. A. Clark, H. C. Pitot, and J. Ross Mammary Tumor Induction in Transgenic Mice Expressing an RNA-Binding Protein Cancer Res., January 1, 2004; 64(1): 209 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Stuhlmuller, E. Kunisch, J. Franz, L. Martinez-Gamboa, M. M. Hernandez, A. Pruss, N. Ulbrich, V. A. Erdmann, G. R. Burmester, and R. W. Kinne Detection of Oncofetal H19 RNA in Rheumatoid Arthritis Synovial Tissue Am. J. Pathol., September 1, 2003; 163(3): 901 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hondermarck Breast Cancer: When Proteomics Challenges Biological Complexity Mol. Cell. Proteomics, May 1, 2003; 2(5): 281 - 291. [Abstract] [Full Text] [PDF]
|
|